MXB Biotechnologies
Founded Year
1993Stage
Corporate Majority - II | AcquiredTotal Raised
$116.44MAbout MXB Biotechnologies
MXB Biotechnologies focuses on the diagnosis of pathological immunohistochemistry in China. The business covers the following major fields: tumor pathological diagnosis, immunocytochemistry diagnosis, molecular pathological diagnosis, and precision medical diagnosis. The leading products are immunohistochemical detection instruments and a series of reagents.On June 13th, 2020, BSBE acquired a majority stake in MXB Biotechnologies.56M.
MXB Biotechnologies Headquarter Location
12F, Haixi Innovation Park Building Gaoxin District, Wulongjiang Middle Blvd.
Fuzhou, Fujian,
China
+86 800-8581156
Expert Collections containing MXB Biotechnologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MXB Biotechnologies is included in 1 Expert Collection, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
When was MXB Biotechnologies founded?
MXB Biotechnologies was founded in 1993.
Where is MXB Biotechnologies's headquarters?
MXB Biotechnologies's headquarters is located at 12F, Haixi Innovation Park Building, Fuzhou.
What is MXB Biotechnologies's latest funding round?
MXB Biotechnologies's latest funding round is Corporate Majority - II.
How much did MXB Biotechnologies raise?
MXB Biotechnologies raised a total of $116.44M.
Who are the investors of MXB Biotechnologies?
Investors of MXB Biotechnologies include BSBE, Sinopharm Investment, CDH Investments, GL Capital, Taikang Life Insurance Company and 3 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.